EUVIMEDEUVIMED entdecken
Open Access

Prospective Evaluation of Contrast-enhanced Mammography for Early Prediction of Pathologic Response after Neoadjuvant Therapy

Lígia Pires-Gonçalves iD, Ana Teresa Aguiar, Conceição Leal, António Guimarães-Santos, Miguel Abreu, Rui Henrique

Radiology: Imaging Cancer · 2025

DOI: 10.1148/rycan.240117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiology: Imaging Cancer, 2025. Verfasst von Lígia Pires-Gonçalves und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Cancer Biology and Epigenetics Group-Research Centre (CI-IPOP), Instituto Português de Oncologia do Porto (IPO-Porto), Fr…. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Breast Neoplasms, Mammography, Contrast Media. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Changes in lesion size measurements at contrast-enhanced mammography after the first cycle of neoadjuvant therapy may be an early predictor of pathologic complete response in individuals with breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyBreast NeoplasmsMammographyContrast MediaHumansFemaleMiddle AgedProspective StudiesPilot ProjectsAdultPredictive Value of TestsSensitivity and SpecificityAged

Stichwörter der Autor:innen

BreastBreast TumorMammographyNeoadjuvant TherapyOncologyPathologic Complete ResponseRadiographic Image EnhancementTumor Response

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Radiology and Cancer Biology and Epigenetics Group-Research Centre (CI-IPOP), Instituto Português de Oncologia do Porto (IPO-Porto), Francisco Gentil EPE, Rua António Bernardino de Almeida, 4200-072 Porto,…
  • Department of Radiology, Instituto Português de Oncologia do Porto (IPO-Porto), Porto, Portugal.
  • Department of Pathology, Instituto Português de Oncologia do Porto (IPO-Porto), Porto, Portugal.
  • Department of Medical Oncology, Instituto Português de Oncologia do Porto (IPO-Porto), Porto, Portugal.
  • Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.

ORCID-Profile: Lígia Pires-Gonçalves

Zitieren

APA

Pires-Gonçalves, L., Aguiar, A. T., Leal, C., Guimarães-Santos, A., Abreu, M., & Henrique, R. (2025). Prospective Evaluation of Contrast-enhanced Mammography for Early Prediction of Pathologic Response after Neoadjuvant Therapy. Radiology: Imaging Cancer. https://doi.org/10.1148/rycan.240117

Vancouver

Pires-Gonçalves L, Aguiar AT, Leal C, Guimarães-Santos A, Abreu M, Henrique R. Prospective Evaluation of Contrast-enhanced Mammography for Early Prediction of Pathologic Response after Neoadjuvant Therapy. Radiology: Imaging Cancer. 2025. doi:10.1148/rycan.240117

BibTeX
@article{PiresGonalves2025,
  author = {Pires-Gonçalves, Lígia and Aguiar, Ana Teresa and Leal, Conceição and Guimarães-Santos, António and Abreu, Miguel and Henrique, Rui},
  title = {Prospective Evaluation of Contrast-enhanced Mammography for Early Prediction of Pathologic Response after Neoadjuvant Therapy},
  journal = {Radiology: Imaging Cancer},
  year = {2025},
  doi = {10.1148/rycan.240117}
}
Kostenlos starten →